Even though her team’s experiments had involved bacteria, she argued that their patent application “specifically states” that the system can be applied in “all organisms” and provides “detailed descriptions of numerous steps that could be taken to apply the system” to humans.14 Zhang argued in his response declaration that Doudna’s application “did NOT [emphasis in the original] have the features required for Cas9 binding and DNA target site recognition in a human cell.”15
